Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

NICE recommends Pfizer’s Sutent

March 26, 2009
Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …

News

NICE rejects Tyverb despite price offer

March 5, 2009
Research and Development NICE, Tyverb

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …

News

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

News

NICE approves Sutent but rejects rivals

February 4, 2009
Sales and Marketing NICE, par

NICE has approved Pfizer's Sutent but rejected three other treatments for kidney cancer. The decision is one of the first …

News

Independent study into NICE’s methods

January 29, 2009
Sales and Marketing NICE, hc

NICE has asked an eminent academic and NHS reformer to conduct an independent study of its approach to appraising new …

News

Sutent to be first to benefit from NICE reform

January 20, 2009
Sales and Marketing NICE, par

Sutent and other rival treatments for renal cell carcinoma look set to be the first drugs to benefit from reforms …

News

Revlimid talks confirm shift in approach to pricing

January 20, 2009
Sales and Marketing NICE, par

Celgene is in negotiations to agree a deal to make its cancer drug Revlimid more affordable to the NHS and …

News

New watchdog warns on NICE adherence

January 19, 2009
Sales and Marketing NICE, hc

The head of the new NHS standards watchdog has indicated that Trusts will be closely monitored for their adherence to …

News

NICE makes end-of-life drugs more available

January 6, 2009
Sales and Marketing NICE, par

High-cost drugs that extend the lives of terminally ill patients will be more readily approved for NHS use, thanks to …

News

NHS to launch clinical data portal

December 17, 2008
Medical Communications NHS, NHS Evidence, NICE, digi, patients

The NHS is building an online portal to store drug information in one place.NHS Evidence will pool clinical data for …

News

SMC criticises PPRS prescribing incentives

December 5, 2008
Sales and Marketing NICE, par

The government move to incentivise doctors for the prescription of new innovative medicines has been criticised by the Scottish Medicines …

News

Rawlins could stay on at NICE

December 4, 2008
NICE

Prof Sir Michael Rawlins could be set to extend his tenure as chairman of NICE, with the government prepared to …

News

Patients use NICE to challenge doctors

December 4, 2008
Sales and Marketing NICE

Patients are increasingly holding doctors to account by bringing NICE guidance with them to consultations. Debate at NICE's annual conference …

News

NICE to collect its own patient data

November 6, 2008
Sales and Marketing NICE

NICE's chairman Prof Sir Michael Rawlins has revealed some details of how it will change to ensure more patients will …

News

Medicine top-ups to be allowed

November 5, 2008
Sales and Marketing NICE, par

The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026